U.S. DNA Manufacturing Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Plasmid DNA, Synthetic DNA), By Grade (GMP & R&D), By Application (Cell & Gene Therapy, Vaccines, Oligonucleotide-based Drugs), By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                     1.1. Market Segmentation and Scope
                     1.2. Market Definitions
                         1.2.1. Type Segment
                         1.2.2. Grade Segment
                         1.2.3. Application Segment
                         1.2.4. End Use Segment
                     1.3. Information analysis
                     1.4. Market formulation & data visualization
                     1.5. Data validation & publishing
                     1.6. Information Procurement
                         1.6.1. Primary Research
                     1.7. Information or Data Analysis
                     1.8. Market Formulation & Validation
                     1.9. Market Model
                     1.10. Objectives
Chapter 2. Executive Summary
                     2.1. Market Outlook
                     2.2. Segment Snapshot
                     2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                     3.1. Market Lineage Outlook
                         3.1.1. Parent market outlook
                         3.1.2. Related/ancillary market outlook
                     3.2. Market Dynamics
                         3.2.1. Market driver analysis
                         3.2.2. Market restraint analysis
                     3.3. DNA Manufacturing Market Analysis Tools
                         3.3.1. Industry Analysis - Porter’s
                         3.3.2. PESTEL Analysis
                         3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. DNA Manufacturing Market: Type Business Analysis
                     4.1. Type Segment Dashboard
                     4.2. U.S. DNA Manufacturing Market Type Movement Analysis
                     4.3. U.S. DNA Manufacturing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                     4.4. Plasmid DNA
                         4.4.1. U.S. Plasmid DNA-based Market, 2018 - 2030 (USD Million)
                     4.5. Synthetic DNA
                         4.5.1. U.S. Synthetic DNA Market, 2018 - 2030 (USD Million)
                             4.5.1.1. Gene Synthesis
                                 4.5.1.1.1. U.S. Synthetic DNA Market, 2018 - 2030 (USD Million)
                             4.5.1.2. Oligonucleotide Synthesis
                                 4.5.1.2.1. U.S. Synthetic DNA Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. DNA Manufacturing Market: Grade Business Analysis
                     5.1. Grade Segment Dashboard
                     5.2. U.S. DNA Manufacturing Market Grade Movement Analysis
                     5.3. U.S. DNA Manufacturing Market Size & Trend Analysis, by Grade, 2018 to 2030 (USD Million)
                     5.4. GMP Grade
                         5.4.1. U.S. GMP Grade Market, 2018 - 2030 (USD Million)
                     5.5. R&D Grade
                         5.5.1. U.S. R&D Grade Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. DNA Manufacturing Market: Application Business Analysis
                     6.1. Application Segment Dashboard
                     6.2. U.S. DNA Manufacturing Market Application Movement Analysis
                     6.3. U.S. DNA Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                     6.4. Cell & Gene Therapy Market
                         6.4.1. U.S. Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
                     6.5. Vaccines
                         6.5.1. U.S. Vaccines Market, 2018 - 2030 (USD Million)
                     6.6. Oligonucleotide-based drugs
                         6.6.1. U.S. Oligonucleotide-based drugs Market, 2018 - 2030 (USD Million)
                     6.7. Others
                         6.7.1. U.S. Others Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. DNA Manufacturing Market: End Use Business Analysis
                     7.1. End Use Segment Dashboard
                     7.2. U.S. DNA Manufacturing Market End Use Movement Analysis
                     7.3. U.S. DNA Manufacturing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                     7.4. Pharmaceutical and Biotechnology Companies
                         7.4.1. U.S. Pharmaceutical and Biotechnology Companies Devices Market, 2018 - 2030 (USD Million)
                     7.5. Academic & Research Institutes
                         7.5.1. U.S. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
                     7.6. Contract Research Organizations
                         7.6.1. U.S. Contract Research Organizations Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                     8.1. Company Categorization
                     8.2. Strategy Mapping
                     8.3. Company Market Position Analysis, 2024
                     8.4. Company Profiles/Listing
                         8.4.1. Charles River Laboratories
                             8.4.1.1. Overview
                             8.4.1.2. Financial Performance
                             8.4.1.3. Service Benchmarking
                             8.4.1.4. Strategic Initiatives
                         8.4.2. VGXI, Inc.
                             8.4.2.1. Overview
                             8.4.2.2. Financial Performance
                             8.4.2.3. Service Benchmarking
                             8.4.2.4. Strategic Initiatives
                         8.4.3. Danaher (Aldevron)
                             8.4.3.1. Overview
                             8.4.3.2. Financial Performance
                             8.4.3.3. Service Benchmarking
                             8.4.3.4. Strategic Initiatives
                         8.4.4. . Thermo Fisher Scientific
                             8.4.4.1. Overview
                             8.4.4.2. Financial Performance
                             8.4.4.3. Service Benchmarking
                             8.4.4.4. Strategic Initiatives
                         8.4.5. Lonza
                             8.4.5.1. Overview
                             8.4.5.2. Financial Performance
                             8.4.5.3. Service Benchmarking
                             8.4.5.4. Strategic Initiatives
                         8.4.6. GenScript
                             8.4.6.1. Overview
                             8.4.6.2. Financial Performance
                             8.4.6.3. Type Benchmarking
                             8.4.6.4. Strategic Initiatives
                         8.4.7. Twist Bioscience
                             8.4.7.1. Overview
                             8.4.7.2. Financial Performance
                             8.4.7.3. Service Benchmarking
                             8.4.7.4. Strategic Initiatives
                         8.4.8. AGC Biologics
                             8.4.8.1. Overview
                             8.4.8.2. Financial Performance
                             8.4.8.3. Service Benchmarking
                             8.4.8.4. Strategic Initiatives
                         8.4.9. Catalent
                             8.4.9.1. Overview
                             8.4.9.2. Financial Performance
                             8.4.9.3. Service Benchmarking
                             8.4.9.4. Strategic Initiatives
                         8.4.10. Eurofins Genomics
                             8.4.10.1. Overview
                             8.4.10.2. Financial Performance
                             8.4.10.3. Service Benchmarking
                             8.4.10.4. Strategic Initiatives

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 U.S. DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 4 U.S. DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
Table 5 U.S. DNA manufacturing market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
Table 6 U.S. DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market snapshot
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market trends & outlook
Fig. 7 Market segmentation & scope
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 PESTLE Analysis
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 U.S. DNA Manufacturing market: Type outlook key takeaways
Fig. 13 U.S. DNA Manufacturing market: Type movement analysis
Fig. 14 Plasmid DNA market, 2018 - 2030 (USD million)
Fig. 15 Synthetic DNA market, 2018 - 2030 (USD million)
Fig. 16 U.S. DNA Manufacturing market: Grade outlook key takeaways
Fig. 17 U.S. DNA Manufacturing market: Grade movement analysis
Fig. 18 GMP Grade market, 2018 - 2030 (USD million)
Fig. 19 R&D Grade market, 2018 - 2030 (USD million)
Fig. 20 U.S. DNA Manufacturing market: Application outlook key takeaways
Fig. 21 U.S. DNA Manufacturing market: Application movement analysis
Fig. 22 Cell & Gene Therapy market, 2018 - 2030 (USD million)
Fig. 23 Vaccines market, 2018 - 2030 (USD million)
Fig. 24 Oligonucleotide-based drugs market, 2018 - 2030 (USD million)
Fig. 25 Others market, 2018 - 2030 (USD million)
Fig. 26 U.S. DNA Manufacturing market: End Use outlook key takeaways
Fig. 27 U.S. DNA Manufacturing market: End Use movement analysis
Fig. 28 Pharmaceutical and Biotechnology Companies market, 2018 - 2030 (USD Million)
Fig. 29 Contract Research Organizations market, 2018 - 2030 (USD Million)
Fig. 30 Academic & Research Institutes market, 2018 - 2030 (USD Million)
Fig. 31 Key companies profiled